Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Collaborative tuberculosis/HIV activities in the European Region

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prognostic factors for work disability in patients with chronic widespread pain and fibromyalgia: protocol for a cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Upper airway symptoms associate with the eosinophilic phenotype of COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Characteristics and impact of exercise-induced laryngeal obstruction: an international perspective

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Severe outcomes of COVID-19 among patients with COPD and asthma

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Gerard de Vries
  • Sarah van de Berg
  • Anke van Dam
  • Sayohat Hasanova
  • Manish Pareek
  • Marieke J van der Werf
  • Daria N Podlekareva
View graph of relations

Introduction: An estimated 12% of tuberculosis (TB) patients are co-infected with HIV in the World Health Organization European Region (the Region). Reducing morbidity and mortality from HIV-associated TB requires strong collaboration between TB and HIV services at all levels with integrated people-centred models of care.

Methods: We collected information on the current models of integration of TB and HIV services in the Region via a comprehensive survey among the TB and HIV National Focal Points, and identified challenges and opportunities.

Results: 47 out of 55 (85%) countries responded. HIV testing in all TB patients and screening for active TB in all people living with HIV (PLHIV) was recommended in 40 (85%) and 34 (72%) countries, respectively. 30 (64%) countries recommended latent TB infection (LTBI) screening in all PLHIV, while 13 (28%) had a selective approach and four (9%) did not recommend LTBI screening. In most countries, testing for HIV and screening for active TB and LTBI was done by the specialist treating the patient, i.e. TB patients were tested for HIV by a TB specialist in 42 (89%) countries and PLHIV were screened for active TB by an HIV specialist in 34 (72%) countries.

Conclusions: TB and HIV care are well integrated in policies of especially high TB and high HIV burden countries; however, implementation needs to be improved. Continuous monitoring of TB and HIV services integration enables assessing the quality of TB/HIV care and to identify where further improvements are needed.

Original languageEnglish
JournalERJ Open Research
Volume7
Issue number1
ISSN2312-0541
DOIs
Publication statusPublished - Jan 2021

ID: 64485898